ACTION OF CHELATING-AGENTS IN REMOVAL OF COPPER FROM CERULOPLASMIN - INVITRO STUDY

被引:27
作者
JACKSON, GE
MAY, PM
WILLIAMS, DR
机构
[1] UWIST,DEPT CHEM,CARDIFF CF1 3NU,S GLAMORGAN,WALES
[2] UNIV ST ANDREWS,DEPT CHEM,ST ANDREWS KY16 9ST,FIFE,SCOTLAND
关键词
D O I
10.1016/0014-5793(78)80323-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:173 / 177
页数:5
相关论文
共 20 条
[11]   COPPER BIOSYSTEMS .41. BINDING OF TRANSITION METAL IONS BY CERULOPLASMIN (FERROXIDASE) [J].
MCKEE, DJ ;
FRIEDEN, E .
BIOCHEMISTRY, 1971, 10 (21) :3880-&
[12]  
MORELL AG, 1964, J BIOL CHEM, V239, P1042
[13]   REINVESTIGATION OF SOME PHYSICOCHEMICAL AND CHEMICAL PROPERTIES OF HUMAN CERULOPLASMIN(FERROXIDASE) [J].
RYDEN, L ;
BJORK, I .
BIOCHEMISTRY, 1976, 15 (16) :3411-3417
[14]   EVIDENCE FOR PROTEOLYTIC FRAGMENTS IN COMMERCIAL SAMPLES OF HUMAN CERULOPLASMIN [J].
RYDEN, L .
FEBS LETTERS, 1971, 18 (02) :321-&
[15]  
Scheinberg I. H., 1973, INORGANIC BIOCH, V1, P306
[16]   EXCHANGE OF CERULOPLASMIN COPPER WITH IONIC CU64 WITH REFERENCE TO WILSONS DISEASE [J].
SCHEINBERG, IH ;
MORELL, AG .
JOURNAL OF CLINICAL INVESTIGATION, 1957, 36 (08) :1193-1201
[17]   PENICILLAMINE, A NEW ORAL THERAPY FOR WILSONS DISEASE [J].
WALSHE, JM .
AMERICAN JOURNAL OF MEDICINE, 1956, 21 (04) :487-495
[18]  
WALSHE JM, 1973, Q J MED, V42, P441
[19]  
WALSHE JM, 1963, CLIN SCI, V25, P405
[20]  
[No title captured]